3 completed, 2 terminated, 2 withdrawn. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Completed 3, Terminated 2, Withdrawn 2 |
Follow Abraxane: new trials by email Literature Review of Abraxane trials Research Report on Abraxane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SMMART Adaptive Clinical Treatment (ACT) Trial Alectinib, Alpelisib, Anastrozole - Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm | Early Phase 1 | Withdrawn | OHSU Knight Cancer Institute | 2023-01-30 | 2024-01-23 | |
| Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer Atezolizumab, Cryosurgery, Nab-paclitaxel - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Early Phase 1 | Withdrawn | Mayo Clinic | 2020-01-23 | 2023-01-06 | |
| Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma Stereotactic Body Radiotherapy, Carboplatin, Paclitaxel Albumin-Stabilized Nanoparticle Formulation - Stage I Non-Small Cell Lung Cancer, Stage II Non-Small Cell Lung Cancer | Early Phase 1 | Terminated | Case Comprehensive Cancer Center | 3 | 2016-02-02 | 2017-02-01 |
| Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer Nab-paclitaxel, Gemcitabine, Cisplatin - Pancreatic Adenocarcinoma | Early Phase 1 | Completed | Baylor Research Institute | 20 | 2016-01-01 | 2021-06-22 |
| Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer Gemcitabine, Abraxane - Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Locally Advanced | Early Phase 1 | Completed | Jean-Luc Van Laethem | 23 | 2013-03-21 | 2020-09-04 |
| Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas Surgery, Genetic Expression, Chemotherapy - Adenocarcinoma Pancreas | Early Phase 1 | Terminated | Medical University of South Carolina | 2 | 2012-07-01 | 2016-03-08 |
| Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer lapatinib ditosylate, paclitaxel albumin-stabilized nanoparticle formulation - Breast Cancer | Early Phase 1 | Completed | Northwestern University | 30 | 2006-05-04 | 2020-03-06 |
Breast Neoplasms (2) · Pancreatic Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1) · Triple Negative Breast Neoplasms (1)
Baylor Research Institute (1) · Case Comprehensive Cancer Center (1) · Jean-Luc Van Laethem (1) · Mayo Clinic (1) · Medical University of South Carolina (1) · Northwestern University (1) · OHSU Knight Cancer Institute (1)
United States (4) · Belgium (1)
Carlos Becerra, MD (1) · Emmanuel M Gabriel (1) · Eric Kimchi, MD (1) · Jean-Luc Van Laethem, MD, PhD (1) · Lara Davis (1) · Mitchell Machtay, MD (1) · Virginia G. Kaklamani, MD (1)
P30CA043703 (1)